Evidence map›Paper›PMID 33738178›Full record

ArticleCurrent addiction reports2020

Wearable and Wireless mHealth Technologies for Substance Use Disorder.

Charlotte Goldfine, Jeffrey T Lai, Evan Lucey, Mark Newcomb, Stephanie Carreiro

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Current addiction reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06629467 (Cognitive Behavioral Treatment With Activity Trackers for Smoking Cessation), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06629467 nacompletednot on this mapstarted 2023, after this paper: background citation

Cognitive Behavioral Treatment With Activity Trackers for Smoking Cessation

TypeinterventionalSponsorUniversity of OviedoRan2023 to 2025Enrolled128ConditionsTobacco Use Cessation, Physical ActivityArmsCognitive-behavioral therapy for smoking cessation, Personalized PA plan, Fitbit Versa 3
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charlotte GoldfineUniversity of Massachusetts Medical School, Department of Emergency Medicine, Division of Medical Toxicology, Worcester, MA.
Jeffrey T LaiUniversity of Massachusetts Medical School, Department of Emergency Medicine, Division of Medical Toxicology, Worcester, MA.
Evan LuceyUniversity of Massachusetts Medical School, Department of Emergency Medicine, Division of Medical Toxicology, Worcester, MA.
Mark NewcombUniversity of Massachusetts Medical School, Department of Emergency Medicine, Division of Medical Toxicology, Worcester, MA.
Stephanie CarreiroUniversity of Massachusetts Medical School, Department of Emergency Medicine, Division of Medical Toxicology, Worcester, MA.
University of Massachusetts Chan Medical School · US

Funding

RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse DisordersR44DA046151 · NIDA · CONTINUEYOU, LLC · PI CARREIRO, STEPHANIE P, GILBERTSON, NICOLE · 2019 to 2022
$1.8M
iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Naïve IndividualsK23DA045242 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARREIRO, STEPHANIE P · 2019 to 2021
$566k
NIDA NIH HHS K23 DA045242NIDA NIH HHS L30 DA038357NIDA NIH HHS R44 DA046151
6 · The paper itself

Abstract

purpose of reviewThe goal of this scoping review is to evaluate the advances in wearable and other wireless mobile health (mHealth) technologies in the treatment of substance use disorders. RECENT

findingsThere are a variety of wireless technologies under investigation for the treatment of substance use disorder. Wearable sensors are the most commonly used technology. They can be used to decrease heavy substance use, mitigate factors related to relapse, and monitor for overdose. New technologies pose distinct advantages over traditional therapies by increasing geographic availability and continuously providing feedback and monitoring while remaining relatively non-invasive. SUMMARY: Wearable and novel technologies are important to the evolving landscape of substance use treatment. As technologies continue to develop and show efficacy, they should be incorporated into multifactorial treatment plans.

Indexed as

biosensormHealthsubstance use disorderwearable sensor

Identifiers

PMID33738178
PMCPMC7963000
OpenAlexW3034563511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.